IMAX's Stock Is up More Than 70% This Year. Here's Why an Analyst Sees More Room to Run.
Wedbush Maintains IMAX Corp(IMAX.US) With Buy Rating, Raises Target Price to $32
Express News | IMAX Corp : Wedbush Raises Target Price to $32 From $26
Wicked, Moana, and Gladiator Are Hitting Theaters. AMC and Cinemark Should Benefit.
Will Glicked Rival Barbenheimer? Stocks to Watch as Wicked, Gladiator II Open in Theaters
IMAX To Present at the 8th Annual Wells Fargo TMT Summit
IMAX Corporation's (NYSE:IMAX) Intrinsic Value Is Potentially 86% Above Its Share Price
Private Capital's Strategic Moves in Q3 2024: A Deep Dive Into Imax Corp's Significant Reduction
B.Riley Financial Maintains IMAX Corp(IMAX.US) With Buy Rating, Raises Target Price to $33
JPMorgan Flags IMAX, H.B. Fuller, ZIM As Top Short Picks With Challenges
Barrington Maintains IMAX Corp(IMAX.US) With Buy Rating, Raises Target Price to $28
A Quick Look at Today's Ratings for IMAX Corp(IMAX.US), With a Forecast Between $26 to $30
Results: IMAX Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
Imax Corp (IMAX) Q3 2024 Earnings Call Highlights: Strong Box Office Performance and System ...
Imax Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Adjusted EPS Results.
Imax to Benefit From More Titles in 2025 Despite Not All Being Hits, Wedbush Says
2025 Looks Like an 'Inflection Year': IMAX CEO
Imax Price Target Maintained With a $24.00/Share by Barrington Research
Imax Is Maintained at Buy by Rosenblatt
Imax Analyst Ratings